XM does not provide services to residents of the United States of America.

IBM and Zynga settle patent lawsuit after $45 million verdict



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-IBM and Zynga settle patent lawsuit after $45 million verdict</title></head><body>

Adds response from Zynga in paragraph 3

By Blake Brittain

Dec 16 -IBM IBM.N has agreed to settle a patent lawsuit against Zynga after it won a $45 million jury verdict against the mobile game maker earlier this year, according to a filing in Delaware federal court.

IBM and Zynga told the court on Friday that they had reached a settlement in principle and asked to pause the case while they finalize it.

A Zynga spokesperson on Monday declined to comment.Spokespeople and attorneys for IBM did not immediatelyrespond on Monday to a request for comment and more information about the settlement.

Armonk, N.Y.-based IBM sued Zynga in 2022 for allegedly infringing patents covering "foundational" internet technology, some of which it developed for its late-1980s internet service Prodigy. IBM also filed and later resolved lawsuits against other internet-based companies, including Chewy, Rakuten and Groupon, over related technology.

In September, a Delaware jury determined that Zynga games, including entries from its "Farmville" series, infringed two IBM patents related to web-based communications. The jury awarded IBM $44.9 million in damages.

Zynga had denied the allegations and argued that the patents were invalid. It asked the court in October to throw out the verdict or hold a new trial.

The case is International Business Machines Corp v. Zynga Inc, U.S. District Court for the District of Delaware, No. 1:22-cv-00590.

For IBM: John Desmarais, Karim Oussayef, Tamir Packin and Tuhin Ganguly of Desmarais LLP

For Zynga: Alyssa Caridis, Clement Roberts and Richard Martinelli of Orrick Herrington & Sutcliffe


Read more:

IBM sues online-game maker Zynga over internet patents

IBM wins $45 mln verdict against Zynga in internet tech patent trial



Reporting by Blake Brittain in Washington

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.